PHASE Scientific Americas develops rapid antigen tests for point-of-care and over-the-counter use, specifically targeting the detection of infectious diseases. Their INDICAID health platform offers at-home collection kits and virtual care services, enabling patients to manage their health more effectively.
Funding
$749.8K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NSFounders
Product
Problem
Current rapid antigen tests often require a visit to a point-of-care facility or pharmacy. This can be inconvenient, time-consuming, and may delay diagnosis and treatment, particularly for individuals in remote areas or with limited mobility.
Solution
PHASE Scientific Americas offers INDICAID, a suite of rapid antigen tests designed for both point-of-care (POC) and over-the-counter (OTC) use, along with the INDICAID health digital platform. The INDICAID platform includes at-home collection kits and virtual care services, enabling individuals to conveniently manage their health from home. The rapid antigen tests focus on the detection of common infectious diseases, providing accessible and timely diagnostic information. This approach aims to empower individuals to proactively monitor their health and make informed decisions in consultation with healthcare providers.
Target Audience
The primary target audience includes individuals seeking convenient at-home health monitoring solutions, healthcare providers needing rapid point-of-care diagnostics, and organizations looking to provide accessible testing options to their employees or communities.
Features
- INDICAID OTC: Over-the-counter rapid antigen tests for at-home use
- INDICAID POC: Point-of-care rapid antigen tests for professional use
- INDICAID health: Digital health platform for at-home collection and virtual care
- At-home collection kits for diabetes (HbA1c) and heart health (Lipid Panel)
- PHASiFY: Proprietary sample preparation technology to advance molecular diagnostic testing
- PHASE Lab: CLIA and CAP accredited high complexity lab